Group 1: Company Overview and Market Position - Shanghai Buke Automation Co., Ltd. has established a strong presence in the robotics industry, focusing on mobile robots and providing tailored solutions based on customer needs [3]. - The company has seen continuous growth in its mobile robotics sector, with applications in AGV/AMR, collaborative robots, construction robots, medical robots, and agricultural robots [3]. - The market share for the company's products has been steadily increasing, driven by trends such as population aging and the growing adoption of robots [3]. Group 2: Product Development and Innovation - The company has developed its third-generation frameless torque motor, achieving a 20% increase in torque and a 30% reduction in weight compared to the second generation, with competitive pricing and technology advantages [4]. - Sales of the frameless torque motor have nearly doubled in 2023, making it one of the fastest-growing products in the company's portfolio [4]. - The company is exploring applications for the frameless torque motor beyond robotics, including in medical devices, semiconductor equipment, and renewable energy sectors [4]. Group 3: Financial and Operational Strategy - For 2024, the company plans to increase R&D investment while maintaining a reasonable expense ratio [4]. - The "Intelligent Manufacturing Production Base Construction Project" is underway, with the first factory expected to be completed in 2024, leading to increased capital expenditure and gradual capacity expansion [4]. - The company aims to enhance product competitiveness and build a high-performance team to support its strategic goals [4]. Group 4: Industry Engagement and Customer Relationships - The company has established deep connections with clients in the medical imaging sector, providing specialized servo drives, motors, and touch screens [4]. - By collaborating with leading companies in the medical imaging industry, the company has been able to innovate and improve product offerings, thus expanding its market share [5]. - The high certification costs in the medical imaging industry result in long product lifecycles, providing stability for the company's strategic focus [4].

上海步科自动化股份有限公司 2023 年年度股东大会 会议资料 2024 年 4 月 17 日 1 / 41 上海步科自动化股份有限公司 2023 年年度股东大会会议资料 上海步科自动化股份有限公司 2023 年年度股东大会会议资料 目 录 | 年年度股东大会会议须知 2023 3 | | --- | | 2023 年年度股东大会会议议程 5 | | 年度董事会工作报告》的议案 议案一：关于《2023 7 | | 议案二：关于《2023 年度监事会工作报告》的议案 8 | | 年度财务决算报告》的议案 议案三：关于《2023 9 | | 议案四：关于《2023 年年度报告》及其摘要的议案 10 | | 议案五：关于 年年度利润分配预案的议案 2023 11 | | 议案六：关于 2024 年董事、监事薪酬方案的议案 12 | | 议案七：关于 年度对外担保额度预计的议案 2024 14 | | 议案八： 关于提请股东大会授权董事会决定以简易程序向特定对象发行股票的 | | 议案 15 | | 议案九：关于董事会换届选举暨选举第五届董事会非独立董事的议案 19 | | 议案十：关于董事会换届选举暨选举第五届董事 ...

海通证券股份有限公司 关于上海步科自动化股份有限公司 2023 年度持续督导年度跟踪报告 | 保荐机构名称：海通证券股份有限公司 | 被保荐公司简称：步科股份 | | --- | --- | | 保荐代表人姓名：郑乾国、秦国亮 | 被保荐公司代码：688160 | 经中国证券监督管理委员会《关于同意上海步科自动化股份有限公司首次公 开发行股票注册的批复》（证监许可[2020]2386 号）批复，上海步科自动化股份 有限公司（以下简称"上市公司"、"公司"或"发行人"）首次公开发行股票 2,100 万股，每股面值人民币 1 元，每股发行价格人民币 20.34 元，募集资金总额为 人民币 42,714.00 万元，扣除发行费用后，实际募集资金净额为人民币 38,145.41 万元。本次发行证券已于 2020 年 11 月 12 日在上海证券交易所科创板上市。海 通证券股份有限公司（以下简称"保荐机构"或"海通证券"）担任其持续督导保 荐机构，持续督导期间为 2020 年 11 月 12 日至 2023 年 12 月 31 日。 在 2023 年 1 月 1 日至 2023 年 12 月 31 日持续督导期内（以下 ...

2023 年 12 月 31 日，持续督导期已届满，海通证券根据《证券发行上市保荐业 务管理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市 公司自律监管规则适用指引第 1 号——规范运作》等法规、规范性文件相关要求， 出具本保荐总结报告书。 海通证券股份有限公司关于上海步科自动化股份有限公司 首次公开发行股票并在科创板上市 之保荐总结报告书 | 保荐机构名称： | 海通证券股份有限公司 | | --- | --- | | 保荐机构编号： | Z22531000 | 经中国证券监督管理委员会《关于同意上海步科自动化股份有限公司首次公开 发行股票注册的批复》（证监许可[2020]2386 号）批复，上海步科自动化股份有限 公司（以下简称"上市公司"、"公司"或"发行人"）首次公开发行股票 2,100 万股，每 股面值人民币 1 元，每股发行价格人民币 20.34 元，募集资金总额为人民币 42,714.00 万元，扣除发行费用后，实际募集资金净额为人民币 38,145.41 元。本次 发行证券已于 2020 年 11 月 12 日在上海证券交易所科创板上市。海通证券股份有限 公司（以下简称" ...

上海步科自动化股份有限公司 证券代码：688160 证券简称：步科股份 公告编号：2024-016 关于全资子公司注销部分募集资金专项账户公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海步科自动化股份有限公司首次公开 发行股票注册的批复》（证监许可【2020】2386 号），同意上海步科自动化股份有 限公司（以下简称"公司"、"步科股份"）首次公开发行股票的注册申请。公司获 准向社会公众公开发行人民币普通股（A 股）股票 2,100 万股，发行价为每股人民 币 20.34 元，共计募集资金 42,714.00 万元，扣除发行费用后，实际募集资金净额为 38,145.41 万元。上述募集资金全部到位，已经天健会计师事务所（特殊普通合伙） 审验，并于 2020 年 11 月 9 日出具天健验〔2020〕3-107 号《验资报告》。公司已对 募集资金进行了专户存储，并与保荐机构、存放募集资金的商业银行签署了相关监 管协议，具体情况详见公司于 2020 年 11 月 ...

Investment Rating - The report maintains a "Hold" rating for Bukoo Technology (688160) with a target price of 51.19 RMB [1] Core Views - The company's gross margin remained stable, while management and R&D expenses increased, leading to a decline in net profit margin [1] - The robot business grew by 30% year-on-year, with expected order growth rates of 30% for 2024-2026 [3] - The medical imaging equipment business saw a decline of 21.42% in 2023 but is expected to grow by 30% in 2024 [32] - The machine IoT business is expected to grow at 20%, 15%, and 15% for 2024-2026 respectively [14] - The general automation business declined by 29.75% in 2023 but is expected to grow by 30% in 2024 [47] Financial Performance - In 2023, the company achieved revenue of 506.48 million RMB, a year-on-year decrease of 6.09%, and net profit of 60.68 million RMB, a year-on-year decrease of 33.36% [11] - The gross margin in 2023 was 38.18%, with a slight increase of 0.24pp year-on-year [1] - The net profit margin in 2023 was 12.03%, a decrease of 4.80pp year-on-year [1] - The company's ROE in 2023 was 8.10%, with expected increases to 10.22%, 12.05%, and 13.84% for 2024-2026 respectively [30] Business Segments - The robot business achieved revenue of 189.22 million RMB in 2023, a year-on-year increase of 30.60% [43] - The medical imaging equipment business achieved revenue of 34.87 million RMB in 2023, a year-on-year decrease of 21.42% [43] - The machine IoT business achieved revenue of 156.63 million RMB in 2023, a year-on-year decrease of 7.40% [43] - The general automation business achieved revenue of 122.72 million RMB in 2023, a year-on-year decrease of 29.75% [43] Market Position - The company holds a 13% market share in the DC servo market, ranking first in 2022 [43] - In the mobile robot industry, the company holds a 42% market share in the DC servo supplier segment, ranking first in 2022 [43] Future Projections - The company is expected to achieve net profits of 84.15 million RMB, 110.52 million RMB, and 143.79 million RMB for 2024-2026 respectively [22] - The compound annual growth rate (CAGR) of net profit is expected to be 33% for the next three years [22] - The PE ratios for 2024-2026 are projected to be 52X, 39X, and 30X respectively [22] Industry Analysis - The industrial automation industry is highly competitive, with the company maintaining stable gross margins through new product launches and cost control [4] - The company is expected to achieve gross margins of 38.5%, 39.0%, and 39.0% for 2024-2026 respectively [4]

Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the fiscal year, representing a 15% year-over-year growth[18]. - The company's operating revenue for 2023 was CNY 506,480,267.79, a decrease of 6.09% compared to CNY 539,306,528.56 in 2022[26]. - Net profit attributable to shareholders was CNY 60,683,399.68, representing a decline of 33.36% from CNY 91,055,542.86 in the previous year[26]. - The basic earnings per share decreased by 33.33% to CNY 0.72 from CNY 1.08 in 2022[27]. - The diluted earnings per share also fell to CNY 0.72, down 33.33% from CNY 1.08 in the previous year[28]. - The gross profit margin for 2023 was 38.07%, an increase from 37.92% in 2022[99]. - The company achieved operating revenue of 506.48 million yuan, a decrease of 6.09% year-on-year[35]. - The company reported a total of CNY 6,866,819.01 in non-recurring gains for 2023, compared to CNY 4,307,899.47 in 2022[31]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of 3 RMB per 10 shares, totaling 25.2 million RMB (before tax) based on a total share capital of 84 million shares as of December 31, 2023[6]. - The company has a cash dividend policy that mandates a minimum of 10% of the distributable profit to be distributed annually, with a cumulative minimum of 30% over three years[185]. - The company declared a cash dividend of 3.00 RMB per 10 shares, totaling 25,200,000.00 RMB, which represents 41.53% of the net profit attributable to ordinary shareholders in the consolidated financial statements[190]. Research and Development - The company is investing in AI technology, with a budget allocation of 100 million CNY for research and development[18]. - Research and development expenses accounted for 11.38% of operating revenue, up from 8.63% in 2022, indicating increased investment in innovation[28]. - The company holds a total of 117 patents, including 15 invention patents, with 22 new patent applications during the reporting period[42]. - The company’s R&D investment totaled approximately ¥57.65 million, representing a 23.89% increase from the previous year's ¥46.53 million[78]. - The company has established R&D centers in multiple cities including Shanghai, Shenzhen, Chengdu, and Changzhou, enhancing its technological and product innovation capabilities[90]. Market Expansion and Strategy - The company provided guidance for the next fiscal year, projecting a revenue growth of 20% to 1.44 billion CNY[18]. - Market expansion plans include entering two new international markets, targeting a 10% increase in overall market share[18]. - The company is exploring potential acquisitions to enhance its technology portfolio, with a budget of 300 million CNY set aside for this purpose[18]. - The company is focusing on expanding its market presence in sectors such as industrial automation, medical imaging, and renewable energy[82]. - The company plans to enhance its overseas market presence by establishing local service centers and recruiting local sales teams[140]. Corporate Governance - The board of directors has confirmed the authenticity, accuracy, and completeness of the annual report[5]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[8]. - The company has not violated decision-making procedures for providing guarantees[9]. - The company has established specialized committees under the board, including a strategic committee and an audit committee, to enhance governance and operational efficiency[149]. - The company is committed to improving its governance structure in accordance with the Company Law and Securities Law, enhancing decision-making processes[144]. Operational Efficiency and Technology - A new digital factory initiative is being implemented, aimed at improving production efficiency by 30%[18]. - The company has adopted IoT solutions in its operations, which are expected to reduce operational costs by 15%[18]. - The company has developed a digital factory solution that integrates digital technology with automation products, enabling data connectivity for machine and factory management[70]. - The company has implemented a scientific human resource management system to enhance organizational vitality and attract high-end professional talent[47]. - The company has made significant advancements in core technologies, focusing on industrial automation, robotics, and factory digitization, with multiple intellectual property rights acquired[67]. Risks and Challenges - The company has outlined potential risks in its annual report, which investors should consider[5]. - The company faces risks related to insufficient R&D investment and potential loss of key technical personnel, which could impact its competitive advantage[95]. - The company faced risks related to reliance on imported raw materials, with a significant portion of procurement from overseas suppliers[96]. Employee and Management - The total number of employees in the parent company and major subsidiaries is 688, with 294 in production, 159 in sales, and 170 in technical roles[180]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to RMB 640.34 million[167]. - The company has a labor outsourcing total of 74,611.50 hours, with total payments amounting to 1,919,354.03 CNY[184]. - The company’s training program focuses on enhancing employee skills and overall quality through differentiated learning objectives and courses[183]. Future Outlook - Future guidance indicates a projected revenue growth of approximately 10% year-over-year, driven by new product launches and market expansion efforts[157]. - The company plans to continue expanding its marketing team to support long-term growth, resulting in increased sales expenses[107]. - The company is committed to research and development, with significant investments planned for innovative technologies in the next fiscal year[157].

| | | | 一、审计报告……………………………………………………… 第 | 1—6 | | 页 | | --- | --- | --- | --- | | 二、财务报表……………………………………………………… 第 | 7—14 | | 页 | | （一）合并资产负债表…………………………………………… | 第 | 7 | 页 | | （二）母公司资产负债表………………………………………… | 第 | 8 | 页 | | （三）合并利润表………………………………………………… | 第 | 9 | 页 | | （四）母公司利润表………………………………………………第 | | 10 | 页 | | （五）合并现金流量表……………………………………………第 | | 11 | 页 | | （六）母公司现金流量表…………………………………………第 | | 12 | 页 | | （七）合并所有者权益变动表……………………………………第 | | 13 | 页 | | （八）母公司所有者权益变动表…………………………………第 | | 14 | 页 | | 三、财务报表附注……………………………………………… 第 15—9 ...

公司预计 2024 年度为上述全资子公司提供担保额度合计不超过人民币 （或等值外币）30,000.00 万元，截止本公告披露日，公司已实际提供的担保余 额为人民币 3,700.00 万元。 一、担保情况概述 为满足公司全资子公司深圳步科、常州精纳、成都步科生产经营和业务发 展的需求，保证其业务顺利开展，结合公司 2024 年度发展计划，公司拟在全资 子公司申请信贷业务及日常经营需要时为其提供担保，担保额度预计不超过人 民币 30,000.00 万元（或等值外币）。具体担保金额、担保期限、担保费率、担 保方式等内容，由公司及全资子公司与贷款银行或合作方等机构在以上额度内 共同协商确定，相关担保事项以正式签署的担保文件为准。在上述预计的 2024 年度担保额度范围内，公司可根据实际情况对担保范围内的各子公司分配使用 额度。 证券代码：688160 证券简称：步科股份 公告编号：2024-008 上海步科自动化股份有限公司 关于 2024 年度对外担保额度预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海步科自动化股份有限公司（以下简称"公司"）第四届董事会、监事会 任期将于 2024 年 5 月 13 日届满，根据《公司法》《上海证券交易所科创板股票 上市规则》等法律法规以及《公司章程》等相关规定，公司开展董事会、监事会 换届选举工作，现将董事会、监事会换届选举情况公告如下： 一、董事会换届选举情况 公司于 2024 年 3 月 25 日召开第四届董事会第十六次会议，审议通过了《关 于董事会换届选举暨选举第五届董事会非独立董事的议案》《关于董事会换届选 举暨选举第五届董事会独立董事的议案》，经董事会提名委员会对第五届董事会 董事候选人的任职资格审查，公司董事会同意提名唐咚先生、池家武先生、王石 泉先生、曹海先生为公司第五届董事会非独立董事候选人；提名胡红智先生、温 安林先生、彭钦文先生为公司第五届董事会独立董事候选人，其中温安林先生为 会计专业人士。上述候选人简历请见附件。 上述独立董事候选人胡红智先生已完成上海证券交易所独立董事履职学习 平台的培训课程，独立董事候选人 ...